Predicting the clinical behavior of ovarian cancer from gene expression profiles

International Journal of Gynecological Cancer

Volumn 16, Issue SUPPL. 1, 2006, Pages 147-151

  De Smet, F ^a   Pochet, N L M M ^a   Engelen, K ^a   Van Gorp, T ^b   Van Hummelen, P ^c   Marchal, K ^a   Amant, F ^b   Timmerman, D ^b   De Moor, B L R ^a   Vergote, I B ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Clinical; FIGO stage; Microarrays; Ovarian cancer; Platin resistance

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; PACLITAXEL; PLATINUM DERIVATIVE; RNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; OVARY CANCER; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; PREDICTIVE VALUE OF TESTS;

EID: 33645363016     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00321.x     Document Type: Article

References (19)

1. Trimbos JB Vergote I Bolis G et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer - Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003 95 113 25.
2. Markman M Rothman R Hakes T et al. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 1991 9 389 93.
3. Berchuck A Iversen ES Lancaster JM et al. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol 2004 190 910 25.
4. Schwartz DR Kardia SL Shedden KA et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002 62 4722 9.
5. Lancaster JM Dressman HK Whitaker RS et al. Gene expression patterns that characterize advanced stage serous ovarian cancers. J Soc Gynecol Investig 2004 11 51 9.
6. Welsh JB Zarrinkar PP Sapinoso LM et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001 98 1176 81.
7. Jazaeri AA Yee CJ Sotiriou C Brantley KR Boyd J Liu ET. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst 2002 94 990 1000.
8. Lu KH Patterson AP Wang L et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004 10 3291 300.
9. Puskas LG Zvara A Hackler L Jr. Van Hummelen P. RNA amplification results in reproducible microarray data with slight ratio bias. Biotechniques 2002 32 1330 4 1336, 1338, 1340.
10. Brazma A Hingamp P Quackenbush J et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001 29 365 71.
11. Yang YH Dudoit S Luu P et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002 30 e15.
12. Dawson-Saunders B Trapp RG. Basic & clinical biostatistics 2nd edn. CT Appleton & Lange 1994.
13. Troyanskaya OG Garber ME Brown PO Botstein D Altman RB. Nonparametric methods for identifying differentially expressed genes in microarray data. Bioinformatics 2002 18 1454 61.
14. De Smet F Moreau Y Engelen K Timmerman D Vergote I De Moor B. Balancing false positives and false negatives for the detection of differential expression in malignancies. Br J Cancer 2004 91 1160 5.
15. Storey JD Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003 100 9440 5.
16. Quackenbush J. Computational analysis of microarray data. Nat Rev Genet 2001 2 418 27.
17. Pochet N De Smet F Suykens JAK De Moor BLR. Systematic benchmarking of microarray data classification: assessing the role of nonlinearity and dimensionality reduction. Bioinformatics 2004 20 3185 95.
18. Suykens JAK Van Gestel T De Brabanter J De Moor B Vandewalle J. Least squares support vector machines. Singapore, Singapore World Scientific 2002.
19. Simon R Radmacher MD Dobbin K McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003 95 14 8.